Safety of IL-17A inhibitors in 306 psoriasis patients with or without latent tuberculosis
收藏Mendeley Data2026-04-09 收录
下载链接：
https://data.mendeley.com/datasets/r63vzzcxz4
下载链接
链接失效反馈官方服务：
资源简介：
The research results found that after 48 weeks of IL-17A inhibitor treatment, IFN - γ levels in psoriasis patients increased compared to baseline. Adequate prophylactic anti tuberculosis treatment for LTBI patients can help prevent an increase in IFN - γ levels and did not affect the efficacy and safety of IL-17A inhibitors.
